Section 32
Chapter 31,940

Inhaled nitric oxide and extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn

Takata, M.; Miyasaka, K.; Sakai, H.; Fujiwara, H.; Ito, Y.; Kawano, T.

Acta Paediatrica Japonica Overseas Edition 37(2): 171-173


ISSN/ISBN: 0374-5600
PMID: 7793249
DOI: 10.1111/j.1442-200x.1995.tb03291.x
Accession: 031939983

Persistent pulmonary hypertension of the newborn (PPHN) may occasionally require an invasive treatment with extracorporeal membrane oxygenation (ECMO). Inhaled nitric oxide (NO) has recently been introduced as a selective pulmonary vasodilator for treatment of PPHN. We describe a case of PPHN in which neither inhaled NO nor ECMO was effective in reversing pulmonary hypertension. The clinical course of the patient suggested a potential role of NO inhalation in predicting the outcome of ECMO treatment for PPHN.

PDF emailed within 0-6 h: $19.90